跳至主要内容
临床试验/ISRCTN44013133
ISRCTN44013133已完成未知

A Randomised trial of Unruptured Brain Arteriovenous malformations

IH - National Institute of Neurological Disorders and Stroke (USA)0 个研究点目标入组 226 人开始时间: 2006年9月11日最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
226

研究概览

简要总结

2010 protocol in http://www.ncbi.nlm.nih.gov/pubmed/19953376 2013 results in http://www.ncbi.nlm.nih.gov/pubmed/24268105 2020 5-year follow-up results in https://pubmed.ncbi.nlm.nih.gov/32562682/ (added 22/06/2020)

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Patient must have unruptured BAVM diagnosed by Magnetic Resonance Imaging (MRI), Magnetic Resonance Angiography (MRA) and/or angiogram
  • 2. Patient must be 18 years of age or older
  • 3. Patient must have signed informed consent

排除标准

  • 1. Patient has BAVM presenting with evidence of recent or prior hemorrhage
  • 2. Patient has received prior BAVM therapy (endovascular, surgical, radiotherapy)
  • 3. Patient has BAVM deemed untreatable by local team, or has concomitant vascular or brain disease that interferes with/or contraindicts any invasive therapy type (stenosis/occlusion of neck artery, prior brain surgery/radiation for other reasons)
  • 4. Patient has baseline Rankin more than or equal to two
  • 5. Patient has concomitant disease reducing life expectancy to less than ten years
  • 6. Patient has thrombocytopenia (less than 100,000/nl)
  • 7. Patient has coagulopathy (spontaneous or iatrogenic Inernational Normalised Ratio(INR) more than 1.5, Prothrombin Time (PT) more than 30)
  • 8. Patient is pregnant, lactating, or plans to become pregnant
  • 9. Patient has known allergy against iodine contrast agents
  • 10. Patient has multiple-foci BAVMs
  • 11. Patient has any form of arteriovenous or spinal fistulas
  • 12. Patient has a diagnosed Vein of Galen type malformation
  • 13. Patient has a diagnosed cavernous malformation
  • 14. Patient has a diagnosed dural arteriovenous fistula
  • 15. Patient has a diagnosed venous malformation
  • 16. Patient has a diagnosed neurocutaneous syndrome such as cerebro-retinal angiomatosis (von Hippel-Lindau), encephalo-trigeminal syndrome (Sturge-Weber), or Wyburn-Mason syndrome
  • 17. Patient has diagnosed BAVMs in context of moya-moya-type changes
  • 18. Patient has diagnosed hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber)

研究者

发起方
IH - National Institute of Neurological Disorders and Stroke (USA)

相似试验

A randomised trial of unruptured brain arteriovenous... | 临床试验